Page 29 - 2020-2021 HANDBOOK - AUGUST 2020 EDITION

C.1.e. A transgender female [MTF] student-athlete who has received a medical exception for treatment with
testosterone suppression may compete with women on a mixed team until completion of one calendar year
of testosterone suppression treatment.

C.1.f. A MTF student-athlete being treated with testosterone suppression medication, may compete on a women’s
team/competition after completion of one calendar year of testosterone suppression treatment.

C.2. Transgender Athletes NOT Undergoing Hormonal Treatment:

C.2.a. Any transgender student-athlete who is not taking hormone treatment related to gender transition may
participate in sex-segregated sports activities in accordance with their assigned birth gender.
C.2.b. A FTM student-athlete may compete on a male NJCAA team/competition or they may compete on a
female team/competition, however they cannot compete for both teams in one sport.
C.2.c. A MTF student-athlete may not compete on a female NJCAA team / competition; unless the team is
changed from sex-segregated to mixed status.

C.3. The Student-athlete’s Responsibilities:

C.3.a. In order to avoid challenges to a transgender student-athlete’s participation during a sport season, a student-
athlete who has completed, plans to initiate, or is in the process of taking hormones as part of a gender
transition should submit the request to participate on a sports team in writing to the director of athletics upon
matriculation or when the decision to undergo hormonal treatment is made.

C.3.b. The request should include a letter from the student-athlete’s physician documenting the student-
athlete’s intention to transition or the student- athlete’s transition status if the process has already been
initiated. This letter should identify the prescribed hormonal treatment for the student-athlete’s gender
transition and documentation of the student-athlete’s testosterone levels, if relevant.
C.4. The College’s Responsibilities:

C.4.a. The director of athletics should meet with the student-athlete to review eligibility requirements and procedure
for approval of transgender participation.
C.4.b. If hormone treatment is involved in the student-athlete’s transition, the director of athletics should notify the
NJCAA of the student-athlete’s request to participate with a medical exception request.
C.4.c. To assist in educating and in development of institutional policy and practice, a Transgender Participation
Committee should be established. Members of the committee should represent a cross section of the
institutional staff with student-athlete well-being interests, and include representation from the departments
such as: office of general counsel, health and counseling, faculty/academic affairs, and athletics.
C.4.d. All discussions among involved parties and required written supporting documentation should be kept
confidential, unless the student-athlete makes a specific request otherwise. All information about an
individual student-athlete’s transgender identity and medical information, including physician’s information
provided pursuant to this policy, shall be maintained confidentially.

C.5.e Transgender students-athletes will be addressed by their preferred name. Likewise, pronoun references to
the student will reflect the gender with which the student-athlete identifies.